Gene Expression, Genomics and Marketing - Clinical Research Informer

Webinar: How to achieve high-throughput single-cell sequencing

Drug Discovery World

APRIL 17, 2024

It will also feature an introduction by Melanie Masuda, Director of Market Development, ScaleBio. Pooled CRISPR screens offer the ability to knock out or perturb many genes in a single experiment from several hundred to tens of thousands of targets in parallel.

Genome

Genome Genomics Gene Expression RNA

CRISPR screening: Achieving high-throughput single-cell sequencing

Drug Discovery World

APRIL 3, 2024

It will also feature an introduction by Melanie Masuda, Director of Market Development, ScaleBio. Pooled CRISPR screens offer the ability to knock out or perturb many genes in a single experiment from several hundred to tens of thousands of targets in parallel.

Genome

Genome Genomics Gene Expression RNA

CAMP4’s funding influx paves the way for tapping regulatory RNA to treat urea cycle disorders

Pharmaceutical Technology

JULY 29, 2022

The most common marketed drugs in this space aim to address the hyperammonaemia caused by the defective genes in this disorder. Drugs for dialysis, amino acid supplements, and drugs which convert blood ammonia are marketed right now as the go-to urea cycle disorder treatments.

RNA

RNA Gene Expression Gene Gene Therapy

Turning science into business: Amplifying mRNA by targeting regRNAs

Drug Discovery World

APRIL 17, 2024

DDW’s Diana Spencer speaks to Josh Mandel-Brehm , CEO of Massachusetts-based biotech CAMP4, to understand the role regulatory RNAs play in gene expression and how the founders overcame the challenge of launching a business based on brand new science. DS: How easy was it to transfer theoretical research into a viable business?

Gene Expression

Gene Expression Gene Genetic Disease RNA

Alnylam identifies gene to lower abdominal fat and decrease cardiovascular risk

Pharmaceutical Technology

AUGUST 11, 2022

Alnylam Pharmaceuticals and collaborators have identified rare mutations in the INHBE gene that is expressed in the liver, related to a lower waist-to-hip ratio for body mass index (BMI), which is often used as an indicator of abdominal fat and is correlated with the risk of type 2 diabetes (T2D) and coronary heart disease.

Gene

Gene Biobanking Gene Expression In-Vitro

Gene editing: beyond the hype

pharmaphorum

JANUARY 29, 2021

Genome editing is an exciting but still nascent field, and companies in the area face as many obstacles as they do opportunities. Then over the next two or three years, gene therapy was accepted as something that companies got involved in, and several biotechs have been bought up by big pharma.”. The genomic medicine journey.

Gene Editing

Gene Editing Gene Gene Therapy In-Vivo

Right on target: The shift to precision pharmaceuticals

Drug Discovery World

JULY 10, 2023

Think how cell and gene therapies or monoclonal antibodies have become targeted medicines for cancer and you’ll get an idea of the shifting pharmaceutical market. Its convergence with genomics makes sense and we have now multiple examples of AI being used to inform prescribing, diagnostics and drug discovery/ development.

Gene Therapy

Gene Therapy Gene Scientist Gene Editing

Advances in Genetic Medicine May Be Outpacing Some Clinicians’ Understanding, But Pharmaceutical Marketers Can Do Much to Address the Problem

Pharma Marketing Network

DECEMBER 21, 2020

Almost two decades after the human genome was sequenced, a trickle of new genetic medicines (i.e., those that modify the expression of an individual’s genes or repair abnormal genes) has entered clinical practice, including 11 RNA therapeutics, 2 in vivo gene therapies, and 2 gene-modified cell therapies.

Genetics

Genetics Medicine Gene Therapy Marketing

Nutrigenomics: The Future of Personalized Nutrition

Roots Analysis

AUGUST 31, 2023

Nutrigenomics is the science studying the relationship between human genome, nutrition and health. In part, the success of the Human Genome Project has also paved a path for the novel concept of nutrigenomics. Nutrigenomics tests are capable of determining the influence of genes on nutrient requirements and metabolism.

Genome

Genome Genomics Genetics Gene

FAIR Game: making data work harder in the race to market

Drug Discovery World

OCTOBER 17, 2022

By Dr Christof Gänzler, Product Marketing Biology at PerkinElmer Informatics. . In today’s quest to accelerate time to market for novel drugs, part of the success formula requires leveraging discovery data with more precision and speed, and earlier in the process. It takes more than speed to advance and maintain performance.

Marketing

Marketing Scientist Gene Expression Drugs

CRISPR screening: How to achieve 1 million cell data sets cost-effectively

Drug Discovery World

APRIL 11, 2024

It will also feature an introduction by Melanie Masuda, Director of Market Development, ScaleBio. Pooled CRISPR screens offer the ability to knock out or perturb many genes in a single experiment from several hundred to tens of thousands of targets in parallel.

Genome

Genome Genomics Gene Expression RNA

CRISPR screening at scale: An instrument-free, cost-effective approach

Drug Discovery World

MARCH 27, 2024

It will also feature an introduction by Melanie Masuda, Director of Market Development, ScaleBio. Pooled CRISPR screens offer the ability to knock out or perturb many genes in a single experiment from several hundred to tens of thousands of targets in parallel.

Genome

Genome Genomics Gene Expression RNA

International Women’s Day 2024: A Spotlight on 5 Women’s Health Webinars with Xtalks

XTalks

MARCH 7, 2024

Industry professionals will explore the market, innovative formulations and nutritional solutions tailored to empower women toward optimal health and well-being. A significant 58 percent of women worldwide have heightened their use of supplements to support overall wellness.

Hormones

Hormones Genetics Genome Genomics

Roche-UCB’s $120M collaboration; Omega snags $85M; ExeVir raises $27M; GSK culls pipeline meds after failures

Delveinsight

JULY 30, 2020

‘Genome-tuning’ biotech Omega Therapeutics snags USD 85 Million. It will push a pipeline of treatments toward the clinic as well as bankroll the recognition of new targets for genomic medicines. Omega’s platform is designed to adjust gene expression to healthy levels rather than switching genes on and off.

Genome

Genome Genomics Antibody Gene

The future outlook for mRNA therapies

Drug Discovery World

APRIL 30, 2024

The biggest growth driver for mRNA therapeutics came from the Covid-19 pandemic, when mRNA-based vaccines proved effective in treating SARS-CoV-2, and pharmaceutical companies such as Pfizer/BioNTech and Moderna were successful in bringing these treatments to market.

RNA

RNA Protein Vaccination Vaccine

What to expect from SLAS Europe 2023

Drug Discovery World

APRIL 21, 2023

Companies selected for Innovation AveNEW, and who opt-in to compete for the SLAS Ignite Award, will be judged by an SLAS panel on a combination of key concepts, including their marketing plan, market presence and potential, funding prospects, plan for growth and the existence of balanced company leadership, among other qualities.

Doctors

Doctors Doctor Genetics In-Vitro

Synthetic biology tools advancing and accelerating drug discovery efforts

Drug Discovery World

NOVEMBER 15, 2022

First off, genetically encoding desired features into living cells requires designing an appropriate vector, successfully transfecting it across the cell membrane, integrating the new DNA into the host’s genome, and finally, a reporting marker to examine changes. This approach has been around for a while.

DNA

DNA Drugs Antibody Engineer

2020 Year in Review: COVID-19, CRISPR and Immunotherapies Define the Year for the Life Sciences

XTalks

DECEMBER 24, 2020

From isolating SARS-CoV-2 in early January to sequencing its genome shortly thereafter and having a prototype vaccine against it within days, scientific process and progress have held steadfast throughout the pandemic. CRISPR are found in approximately 50 percent of sequenced bacterial genomes and nearly 90 percent of archaea genomes.

Life Science

Life Science Vaccination Vaccine Gene

Clinical Research Informer

Webinar: How to achieve high-throughput single-cell sequencing

CRISPR screening: Achieving high-throughput single-cell sequencing

Trending Sources

CAMP4’s funding influx paves the way for tapping regulatory RNA to treat urea cycle disorders

Turning science into business: Amplifying mRNA by targeting regRNAs

Alnylam identifies gene to lower abdominal fat and decrease cardiovascular risk

Gene editing: beyond the hype

Right on target: The shift to precision pharmaceuticals

Advances in Genetic Medicine May Be Outpacing Some Clinicians’ Understanding, But Pharmaceutical Marketers Can Do Much to Address the Problem

Nutrigenomics: The Future of Personalized Nutrition

FAIR Game: making data work harder in the race to market

CRISPR screening: How to achieve 1 million cell data sets cost-effectively

CRISPR screening at scale: An instrument-free, cost-effective approach

International Women’s Day 2024: A Spotlight on 5 Women’s Health Webinars with Xtalks

Roche-UCB’s $120M collaboration; Omega snags $85M; ExeVir raises $27M; GSK culls pipeline meds after failures

The future outlook for mRNA therapies

What to expect from SLAS Europe 2023

Synthetic biology tools advancing and accelerating drug discovery efforts

2020 Year in Review: COVID-19, CRISPR and Immunotherapies Define the Year for the Life Sciences

Stay Connected